Back to User profile » Dr Ágota Barabássy
Papers published by Dr Ágota Barabássy:
Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum]
Barabássy Á, Sebe B, Acsai K, Laszlovszky I, Szatmári B, Earley WR, Németh G
Neuropsychiatric Disease and Treatment 2021, 17:1481-1482
Published Date: 17 May 2021
Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies
Barabássy Á, Sebe B, Acsai K, Laszlovszky I, Szatmári B, Earley WR, Németh G
Neuropsychiatric Disease and Treatment 2021, 17:957-970
Published Date: 7 April 2021
Relationship between the timing of relapse and plasma drug levels following discontinuation of cariprazine treatment in patients with schizophrenia: indirect comparison with other second-generation antipsychotics after treatment discontinuation
Correll CU, Jain R, Meyer JM, Periclou A, Carrothers T, Barabássy Á, Patel M, Earley W
Neuropsychiatric Disease and Treatment 2019, 15:2537-2550
Published Date: 30 August 2019